Global / PharmaBoardroom's Top 5 Op-Eds in 2021 (So Far)
As our thoughts here at PharmaBoardroom turn towards the summer holidays, we are happy to share the five most-read…
Top Stories
Spain / Grifols Invests in Nigerian Manufacturing; Almirall Nabs EMA Approval for AK Treatment; Zendal TB Vaccine Candidate Trials
The latest from Spanish pharma, including the Patent and Trademark Office’s warning of the importance of IP protection for medical advancements, Grifols’ expansion in Africa through a manufacturing plant in…
Turkey / Abdi Ibrahim CEO Talks Biosimilars, M&A, & US Entry
Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s…
Hong Kong / HKEX Biotech IPOs in the First Half of 2021
Three years after the Hong Kong Stock Exchange (HKEX) introduced reforms to allow and support the listing of…
China / Hong Chow Leaves Roche for Big New Role at Merck
In a big career move on a personal level and a sign of China’s continuing significance to global pharma, Hong…
APAC / Liquid Biopsies & The Future of Cancer Diagnostics
In 2020, the FDA granted its first approval to a comprehensive liquid biopsy, potentially representing a paradigm…
Singapore / Chronic Disease: A Gathering Storm
Singapore is one of the healthiest countries in Asia with a life expectancy in excess of 82 years buttressed by one…
In Conversation
Ida Sofie Jensen – CEO, The Danish Association of the Pharmaceutical Industry (Lif)
Ida Sofie Jensen introduces the strong fundamentals underpinning the Danish innovative life sciences industry, including governmental support for early access to medicines, a collaborative approach to pricing and reimbursement, a highly centralised hospital system, and excellent digitalised patient records. Jensen highlights that thanks to these fundamentals, Denmark is home to the highest number of clinical trials per capita in Europe…
Latest Reports
Focus on Singapore
Building a Globally Competitive Innovation Ecosystem in…
Singapore recently outlined its latest Research, Innovation and Enterprise (RIE)…
Pharma Faces: Marine Queniart-Stojanovic, Sanofi Thailand,…
Industry veteran Marine Queniart-Stojanovic, a self-described “global citizen…
Chronic Disease: A Gathering Storm in Singapore
Singapore is one of the healthiest countries in Asia with a life expectancy in…
Singapore: A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth…
Read more: Singapore >>
Focus on Europe
Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty…
EU’s Beating Cancer Plan: Making it Our Own
Jasper Kunow, MSD’s managing director for Central Eastern Europe, outlines the…
Top 10 Pharma Companies in Ireland 2021
The Top 10 pharma companies in Ireland, ranked by annual turnover in The Irish…
Danish Life Sciences: A Force to Be Reckoned With
On April 16, the Danish government unveiled, to great anticipation and fanfare,…
Read more: Europe >>
Focus on Turkey
How Pricing is Straining Turkish Pharma’s Sustainability
Almost two decades after initiating large-scale health system reforms, Turkey…
Turkey’s Moment of Reckoning on Diabetes?
As COVID-19 began spreading through the world, the race to understand the…
Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her…
Turkey Pharma Industry Data Snapshot 2021
According to a recent report by IEIS, Turkey’s Pharmaceutical Manufacturers…
Read more: Turkey >>
Focus on Vaccines
Morocco Signs Recipharm & Sinopharm Deals on Road to…
After implementing the most successful COVID-19 inoculation campaign on the…
Africa’s Biggest Pharma Company Gets $700 million for…
With Africa struggling to vaccinate its populations against COVID-19, the World…
Brazil Pharma News: EMS Sales Soar; Irregularities in Indian…
The latest news from Brazilian pharma, including an investigation into the…
Mexico Pharma News: Bayer Targets Cancer; Novartis Gets…
The latest news from Mexican pharma, including Bayer’s big bet on oncology and…
Read more: Vaccines >>
Focus on Saudi Arabia
Georg Schroeckenfuchs of Novartis: ‘Shooting for the…
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the…
Pharma Faces: Dimitri Livadas, Lilly Saudi Arabia
Having commenced his journey with American giant Lilly in 2008, and after almost…
Saudization: Local Staffing Obligations & Big…
Historically dependent on oil, Saudi Arabia, like most countries in the Arabian…
PharmaBoardroom’s Top 10 Most Read Interviews of 2021 (So…
PharmaBoardroom has spread its wings far and wide in 2021 (albeit digitally!),…
Read more: Saudi Arabia >>
Focus on China
PharmaBoardroom’s Top 5 Op-Eds in 2021 (So Far)
As our thoughts here at PharmaBoardroom turn towards the summer holidays, we are…
China Pharma Roundup: Sinopharm Tops Brand Value Rankings;…
The latest news from the Chinese pharmaceutical industry, including recent deals…
Hong Kong: HKEX Biotech IPOs in the First Half of 2021
Three years after the Hong Kong Stock Exchange (HKEX) introduced reforms to…
China Enters CAR-T Era with Fosun-Kite Yescarta Approval
A historic approval for Fosun-Kite’s CAR-T therapy Yescarta in China looks set…
Read more: China >>
Focus on Switzerland
PharmaBoardroom’s Top 10 Most Read Interviews of 2021 (So…
PharmaBoardroom has spread its wings far and wide in 2021 (albeit digitally!),…
Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty…
Ticino Looking to Innovative Future With Big New Investment
The small Italian-speaking Canton of Ticino, nestled away in Southern…
Switzerland’s Upcoming Cost Containment Packages:…
While once considered the land of milk and honey within Europe in terms of…
Read more: Switzerland >>
Focus on USA
US Health Policy: FDA Calls for Federal Investigation of…
The latest from US health care policy, including the Senate budget deal funding…
Aducanumab Approval: Opening the Floodgates for a New Era of…
With the US FDA’s controversial recent decision to approve Biogen and…
Inserting the Patient Voice: Ethical Challenges in the Use…
Patient advocate and regular PharmaBoardroom contributor Monica Weldon examines…
US Generics & Biosimilars: Five Takeaways from Access!…
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five…